Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05696210

Evaluation of the 1-year Prognosis of Patients Under Veno-arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock With Blood Transfusion Requirement

Conditions: Extracorporeal Membrane Oxygenation Complication, Blood Cells Transfusion, Transfusion Related Complication

Sex: All
Ages: 18 Years – 99 Years
Enrollment: 110
Sponsor: Central Hospital, Nancy, France

Summary

The primary objective of this work is to study the 1-year prognosis of patients who received Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock with the need for blood transfusion. Secondary objectives are to determine whether the transfusion strategy used (liberal or restrictive) still has an impact on overall mortality. We will also determine the factors associated with overall in-hospital mortality and look at the impact of transfusion in relation to the risk of hemolysis on the consequences in the occurrence of long-term chronic renal failure.

Eligibility Criteria

Inclusion Criteria:Patient of legal age (> 18 years) at the time of data collection.Hospitalization in intensive care unitCardiogenic shock of medical or surgical etiology according to the SCAI definition (stage B to E)Need for cardio-circulatory assistance such as Veno-arterial extracorporeal membrane oxygenation for at least 24 hoursExclusion Criteria:- Age < 18 yearsIn-hospital and out-of-hospital cardiac arrest.Veno-arterial extracorporeal membrane oxygenation set up at a center other than the study centers.Veno-arterial extracorporeal membrane oxygenation set up for less than 24 hoursDeath within 24 hours

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05696210). StuddyBuddy aggregates publicly available trial information.